Veterinary Medicine Information website

Nisamox 40 mg/10 mg Tablets for Dogs and Cats

Authorised
  • Potassium clavulanate
  • Amoxicillin trihydrate
Download as PDF

Product identification

Medicine name:
Nisamox 40 mg/10 mg Tablets for Dogs and Cats
Active substance:
  • Potassium clavulanate
  • Amoxicillin trihydrate
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Potassium clavulanate
    10.00
    milligram(s)
    /
    1.00
    Tablet
  • Amoxicillin trihydrate
    40.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CR02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:
  • bottle containing 100 tablets
  • bottle containing 500 tablets
  • box containing 100 tablets (10 blister)
  • box containing 20 tablets (2 blister)
  • box containing 500 tablets (50 blister)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Norbrook Laboratories (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Norbrook Laboratories Limited
  • Norbrook Laboratories (Ireland) Limited
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 103672
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0348/001
Concerned member states:
  • Italy

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 15/10/2024
Download

Summary of Product Characteristics

English (PDF)
Published on: 22/10/2025
Download

Package Leaflet

English (PDF)
Published on: 22/10/2025
Download